NYSE : ZTS

Zoetis Inc.

$76.56 USD

-$0.35 (-0.46%)

Volume
4.47M
Average Volume
7.34M
Market Capitalization
$32.1B
P/E Ratio
12.68
Dividend Yield
2.69%
Price Target
$99.00
Year High
$160.48
Year Low
$71.47
Day High
Day Low
Payout Ratio
$0.34
Current Ratio
$3.15
Source Headline
Zoetis Inc. (ZTS) Investors: July 27, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP

Did you buy ZTS securities between January 14, 2025, and May 6, 2026? Did you buy ZTS securities between January 14, 2025, and May 6, 2026?

globenewswire.com - 2026-07-18 09:40:00

ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ZTS

New York, New York--(Newsfile Corp. - July 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-17 18:51:00

DEADLINE ALERT for CALX, AVAV, ZTS, LCID: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., July 17, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

globenewswire.com - 2026-07-17 12:37:00

Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - July 17, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law

feeds.newsfilecorp.com - 2026-07-17 12:00:00

ZTS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Zoetis Inc. Securities Lawsuit - Contact The Gross Law Firm

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zoetis Inc. (NYSE: ZTS).

globenewswire.com - 2026-07-17 10:17:00

Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZOETIS INC. (ZTS), CLICK HERE  BEFORE JULY 27, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

prnewswire.com - 2026-07-16 15:39:00

ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTS

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”), of the important July 27, 2026 lead plaintiff deadline.

globenewswire.com - 2026-07-16 14:12:00

Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zoetis securities between January 14, 2025 and May 6, 2026, both dates inclusive (the “Class Period”).

globenewswire.com - 2026-07-16 12:00:00

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of July 27, 2026 in Zoetis Inc. Lawsuit - ZTS

Wall Street's Reassessment of Zoetis Accelerated as Analyst Downgrades Followed Each Corrective Disclosure, Reflecting Growing Skepticism That Management's Companion Animal Growth Narrative Was Built on Concealed Competitive and Safety Deterioration NEW YORK, July 16, 2026 /PRNewswire/ -- Sell-side coverage of Zoetis Inc. (NYSE: ZTS) shifted dramatically over a nine-month span successive revelations forced analysts to reprice the animal health leader's growth assumptions. SueWallSt notifies investors who purchased ZTS securities between January 14, 2025 and May 6, 2026 that a securities class action has been filed.

prnewswire.com - 2026-07-16 10:09:00

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines - ZTS

NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS).   Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

prnewswire.com - 2026-07-16 10:00:00

ZOETIS INC. (ZTS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Zoetis Inc. Investors of Upcoming Deadline

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) investors of the  July 27, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The Zoetis Class Action Lawsuit : Do you, or did you, own shares of Zoetis Inc. (NYSE: ZTS)?

globenewswire.com - 2026-07-16 09:16:00

Zoetis Deadline: ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit

NEW YORK, July 15, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. So What: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

prnewswire.com - 2026-07-15 22:00:00

ZOETIS DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ZTS

New York, New York--(Newsfile Corp. - July 15, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-15 20:12:00

Zoetis Inc. (ZTS) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact KTMC

Did you buy ZTS securities between January 14, 2025, and May 6, 2026? Affected ZTS Investor Summary Who: Zoetis Inc. (NYSE: ZTS) What: Securities fraud class action lawsuit filed Class Period: January 14, 2025 through May 6, 2026 Deadline to Seek Lead Plaintiff Status: July 27, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's product adoption.

prnewswire.com - 2026-07-15 14:37:00

Levi & Korsinsky Reminds Zoetis Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 27, 2026 - ZTS

Notice to Pension Funds, Asset Managers, and Fiduciaries: Zoetis' Companion Animal Segment Collapse Allegedly Cost Institutional Portfolios Hundreds of Millions NEW YORK, July 15, 2026 /PRNewswire/ -- Institutional investors holding positions in Zoetis Inc. (NYSE: ZTS) during the period January 14, 2025 through May 6, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment.

prnewswire.com - 2026-07-15 10:11:00

Zoetis Launches Lenivia® (izenivetmab injection) in Canada and the European Union

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) today announced that it has recently launched Lenivia® (izenivetmab injection) in Canada and the European Union (EU) member states – a new long-acting monoclonal antibody (mAb) therapy designed to deliver up to three months of osteoarthritis (OA) pain management with a single subcutaneous injection. Backed by a decade of science and research, Lenivia demonstrated a sustained reduction in pain in a pivotal nine-month European field study.

businesswire.com - 2026-07-15 08:30:00

Zoetis (ZTS) Stock Dips While Market Gains: Key Facts

Zoetis (ZTS) closed at $74.07 in the latest trading session, marking a -1.75% move from the prior day.

zacks.com - 2026-07-14 19:16:12

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines – ZTS

NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. com or 646-581-9980, (or 888. 4-POMLAW), toll-free, Ext.

globenewswire.com - 2026-07-14 17:04:49

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines – ZTS

NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS).   Such investors are advised to contact Danielle Peyton at  [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

globenewswire.com - 2026-07-14 17:04:00

ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ZTS

New York, New York--(Newsfile Corp. - July 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-14 13:48:00

Deadline Alert: Zoetis Inc. (ZTS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, July 14, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 27, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) securities between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”).

globenewswire.com - 2026-07-14 13:25:00

ZTS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Zoetis Inc. Securities Lawsuit - Contact SueWallSt

Zoetis CEO Kristin Peck and CFO Wetteny Joseph Face Personal Liability for Allegedly Certifying Misleading Statements About Companion Animal Product Performance While Safety Concerns and Competitive Losses Mounted Zoetis CEO Kristin Peck and CFO Wetteny Joseph Face Personal Liability for Allegedly Certifying Misleading Statements About Companion Animal Product Performance While Safety Concerns and Competitive Losses Mounted

globenewswire.com - 2026-07-14 10:54:00

ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm

NEW YORK, July 14, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zoetis Inc. (NYSE: ZTS). Shareholders who purchased shares of ZTS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

prnewswire.com - 2026-07-14 10:07:00

Portnoy Law Firm Announces Class Action on Behalf of Zoetis, Inc. Investors

LOS ANGELES, July 14, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Zoetis, Inc., (“Zoetis” or the "Company") (NYSE: ZTS) investors of a class action on behalf of investors that bought securities between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”). Zoetis investors have until July 27, 2026 to file a lead plaintiff motion.

globenewswire.com - 2026-07-14 09:39:00

Zoetis Announces Agreement to Acquire VitalRADS, Accelerating Diagnostic Capabilities

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. today announced its agreement to acquire VitalRADS, a veterinary teleradiology services platform. Building on the partnership with VitalRADS that Zoetis announced in August 2025, this acquisition adds around-the-clock access to board-certified veterinary specialists through a cloud-based teleradiology platform. Integrating VitalRADS' capabilities into Zoetis' Global Diagnostics portfolio enhances Zoetis' reference laboratory services, delivering AI.

businesswire.com - 2026-07-14 09:00:00

Zoetis: Buy When There Is Blood In The Streets

Zoetis has long been viewed as a high-quality compounder. However, after reaching an all-time high of $249.27 in December 2021, the stock is now caught in a ~70% drawdown. This can be primarily attributed to the dismal performance of the company's crown jewel asset, namely the U.S. companion animal business. After delivering an impressive 25% organic growth during the full year of 2021, the U.S. companion animal business reported dismal performance in Q1-26, with an organic decline of 11%.

seekingalpha.com - 2026-07-14 06:19:50

Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zoetis securities between January 14, 2025 and May 6, 2026, both dates inclusive (the “Class Period”).

globenewswire.com - 2026-07-13 12:00:00

ZTS Shareholder Alert: July 27, 2026 Lead Plaintiff Deadline in Zoetis Inc. Securities Class Action - Contact Levi & Korsinsky

NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP highlights the contrast between Zoetis Inc.'s (NYSE: ZTS) promises to investors and the reality that emerged across four corrective disclosures. Shareholders who purchased ZTS securities between January 14, 2025 and May 6, 2026 and suffered losses may be entitled to compensation.

globenewswire.com - 2026-07-13 10:00:00

Zoetis Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ZTS

LOS ANGELES, July 13, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Zoetis Inc. ("Zoetis" or "the Company") (NYSE: ZTS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of ZTS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

prnewswire.com - 2026-07-13 04:22:00

ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, July 13, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zoetis Inc. ("Zoetis" or "the Company") (NYSE: ZTS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), are encouraged to contact the firm before July 27, 2026.

prnewswire.com - 2026-07-13 04:10:00

ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ZTS

New York, New York--(Newsfile Corp. - July 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-12 16:07:00

Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - July 12, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zoetis securities between January 14, 2025 and May 6, 2026, both dates inclusive (the "Class Period").

newsfilecorp.com - 2026-07-12 12:00:00

ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ZTS

New York, New York--(Newsfile Corp. - July 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-11 10:16:00

10 Dividend Growth Stocks: July 2026

I define dividend growth stocks as those with dividend increases of 5 or more consecutive years. In this monthly series, I rank a selection of dividend growth stocks and present the top 10 stocks for consideration. This month, I'm presenting the top 10 dividend growth stocks with a 5-year yield-on-cost of 2.5% or higher and a consensus upside of at least 5%.

seekingalpha.com - 2026-07-11 09:00:00

Zoetis Deadline: ZTS Investors with Losses in Excess of $100K Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit

NEW YORK, July 10, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. So What: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

prnewswire.com - 2026-07-10 19:26:00

ZOETIS DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTS

NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”), of the important July 27, 2026 lead plaintiff deadline.

globenewswire.com - 2026-07-10 17:49:00

Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES, July 10, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS). IF YOU SUFFERED A LOSS ON YOUR ZOETIS INVESTMENTS, CLICK  HERE BEFORE JULY 27, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

prnewswire.com - 2026-07-10 14:50:00

Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors to Contact the Firm Before the July 27th Lead Plaintiff Deadline

Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Zoetis (ZTS) To Contact Them Directly To Discuss Their Options Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Zoetis (ZTS) To Contact Them Directly To Discuss Their Options

globenewswire.com - 2026-07-10 12:51:00

A Dividend Portfolio That Pays For Your Pets

Rescuing a dog or cat can easily turn into a 10- to 20-year financial commitment. Medium-sized dogs often live around 10 to 13 years, while many cats live into their mid-teens and some stretch past 18. The bill that comes with that lifespan is the part many owners never total, because the monthly receipts feel... A Dividend Portfolio That Pays For Your Pets

247wallst.com - 2026-07-10 12:30:07

ZTS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Zoetis Inc. Securities Lawsuit - Contact The Gross Law Firm

NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zoetis Inc. (NYSE: ZTS). Shareholders who purchased shares of ZTS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

globenewswire.com - 2026-07-10 09:00:00

ZTS FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ZTS

New York, New York--(Newsfile Corp. - July 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-09 18:05:00

DEADLINE ALERT for CALX, AVAV, ZTS, LCID: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., July 09, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

globenewswire.com - 2026-07-09 13:37:00

Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zoetis securities between January 14, 2025 and May 6, 2026, both dates inclusive (the “Class Period”).

globenewswire.com - 2026-07-09 12:00:00

INVESTOR DEADLINE ALERT: Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP

Did you buy ZTS securities between January 14, 2025, and May 6, 2026 ? Affected ZTS Investor Summary Who: Zoetis Inc. (NYSE: ZTS) What: Securities fraud class action lawsuit filed Class Period: January 14, 2025 through May 6, 2026 Deadline to Seek Lead Plaintiff Status: July 27, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's product adoption.

globenewswire.com - 2026-07-09 11:08:00

ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, July 09, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zoetis Inc. (“Zoetis” or “the Company”) (NYSE: ZTS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before July 27, 2026.

globenewswire.com - 2026-07-09 10:23:00

ZOETIS INC. (ZTS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Zoetis Inc. Investors of Upcoming Deadline

NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) investors of the  July 27, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The Zoetis Class Action Lawsuit : Do you, or did you, own shares of Zoetis Inc. (NYSE: ZTS)?

globenewswire.com - 2026-07-09 09:19:00

ZTS FINAL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ZTS

New York, New York--(Newsfile Corp. - July 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

newsfilecorp.com - 2026-07-08 17:59:00

Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - July 8, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law

feeds.newsfilecorp.com - 2026-07-08 12:00:00

ZTS Wins European Commission Approval for New Poultry Disease Vaccine

Zoetis wins EU approval for a single-dose poultry vaccine against Newcastle and Marek's diseases, expanding its vaccine portfolio and flock protection options.

zacks.com - 2026-07-08 11:16:08

Top 50 High-Quality Dividend Growth Stocks For July 2026

I track a curated universe of 50 high-quality dividend growth stocks to identify opportune entry points based on valuation and future return potential. Year-to-date through June, the investable universe returned 8.69%, trailing SPY (10.10%) and SCHD (17.50%), but several individual stocks outperformed significantly. Currently, 39 out of 50 stocks offer a forward return estimate of at least 10%, with 22 appearing potentially undervalued by my free cash flow model.

seekingalpha.com - 2026-07-08 07:42:40

Get ZTS Insider Trade Alerts

ZTS Price Target Summary

Last Month

$88.33

3 analysts

Last Quarter

$101.13

8 analysts

Last Year

$128.76

17 analysts

All Time

$162.62

29 analysts

ZTS Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-06 HSBC Maintain Buy Buy
2026-07-01 Barclays Maintain Equal Weight Equal Weight
2026-06-30 TD Cowen Maintain Buy Buy
2026-06-26 Stifel Maintain Hold Hold
2026-05-27 Argus Research Downgrade Buy Hold
2026-05-22 Stifel Maintain Hold Hold
2026-05-18 Citigroup Maintain Buy Buy
2026-05-08 UBS Maintain Neutral Neutral
2026-05-08 JP Morgan Maintain Overweight Overweight
2026-04-28 UBS Maintain Neutral Neutral
2026-02-13 B of A Securities Maintain Neutral Neutral
2026-01-22 Piper Sandler Downgrade Overweight Neutral
2025-12-03 BTIG Maintain Buy Buy
2025-11-18 Stifel Maintain Hold Hold
2025-11-12 BTIG Maintain Buy Buy
2025-11-10 Morgan Stanley Maintain Overweight Overweight
2025-11-05 JP Morgan Maintain Overweight Overweight
2025-11-05 UBS Maintain Neutral Neutral
2025-10-20 UBS Maintain Neutral Neutral
2025-09-09 Argus Research Maintain Buy Buy
2025-08-11 Piper Sandler Maintain Overweight Overweight
2025-07-17 Leerink Partners Downgrade Outperform Market Perform
2025-06-18 Stifel Downgrade Buy Hold
2025-05-12 Piper Sandler Maintain Overweight Overweight
2025-05-07 UBS Maintain Neutral Neutral
2025-04-14 Stifel Maintain Buy Buy
2025-02-27 Piper Sandler Maintain Overweight Overweight
2025-02-14 Morgan Stanley Maintain Overweight Overweight
2025-02-14 Barclays Maintain Overweight Overweight
2025-02-10 Piper Sandler Maintain Overweight Overweight
2025-01-29 Morgan Stanley Maintain Overweight Overweight
2025-01-07 Stifel Maintain Buy Buy
2024-10-11 JP Morgan Maintain Overweight Overweight
2024-09-18 Stifel Maintain Buy Buy
2024-08-27 Stifel Maintain Buy Buy
2024-08-14 Piper Sandler Maintain Overweight Overweight
2024-08-12 BTIG Maintain Buy Buy
2024-08-07 Barclays Maintain Overweight Overweight
2024-08-05 Stifel Maintain Buy Buy
2024-05-08 HSBC Maintain Buy Buy
2024-05-06 Goldman Sachs Maintain Buy Buy
2024-04-30 Stifel Maintain Buy Buy
2024-04-23 Barclays Maintain Overweight Overweight
2024-04-16 Piper Sandler Maintain Overweight Overweight
2024-04-02 Stifel Maintain Buy Buy
2024-02-20 Piper Sandler Maintain Overweight Overweight
2024-02-14 Barclays Maintain Overweight Overweight
2024-01-17 Goldman Sachs Maintain Buy Buy
2023-11-06 Piper Sandler Maintain Overweight Overweight
2023-10-30 Stifel Maintain Buy Buy
2023-09-12 Stifel Maintain Buy Buy
2023-08-28 Stifel Maintain Buy Buy
2023-08-14 Piper Sandler Maintain Overweight Overweight
2023-08-10 Goldman Sachs Maintain Buy Buy
2023-06-14 Atlantic Equities Maintain Overweight Overweight
2023-05-26 Atlantic Equities Maintain Overweight Overweight
2023-05-08 Piper Sandler Maintain Overweight Overweight
2023-02-21 Barclays Maintain Overweight Overweight
2022-11-15 Morgan Stanley Maintain Overweight Overweight
2022-11-04 B of A Securities Maintain Buy Buy
2022-11-04 Goldman Sachs Maintain Buy Buy
2022-10-17 JP Morgan Maintain Overweight Overweight
2022-07-21 Goldman Sachs Maintain Buy Buy
2022-06-29 Stifel Maintain Buy Buy
2022-06-24 Stifel Maintain Buy Buy
2022-06-17 Argus Research Maintain Buy Buy
2022-05-19 Goldman Sachs Maintain Buy Buy
2022-03-09 Citigroup Maintain Neutral Neutral
2022-02-16 B of A Securities Maintain Buy Buy
2022-01-10 Barclays Maintain Overweight Overweight
2022-01-07 Stifel Maintain Buy Buy
2021-12-20 Citigroup Maintain Neutral Neutral
2021-11-09 Goldman Sachs Maintain Buy Buy
2021-11-05 Barclays Maintain Overweight Overweight
2021-10-27 B of A Securities Maintain Buy Buy
2021-10-26 Stifel Maintain Buy Buy
2021-08-09 Credit Suisse Maintain Outperform Outperform
2021-08-06 Barclays Maintain Overweight Overweight
2021-08-05 Stifel Maintain Buy Buy
2021-07-27 B of A Securities Maintain Buy Buy
2021-07-16 Raymond James Downgrade Outperform Market Perform
2021-05-28 Argus Research Maintain Buy Buy
2021-05-12 Citigroup Maintain Neutral Neutral
2021-05-10 Truist Securities Maintain Hold Hold
2021-05-07 Barclays Maintain Overweight Overweight
2021-05-07 Raymond James Maintain Outperform Outperform
2021-03-08 Raymond James Upgrade Market Perform Outperform
2021-03-08 B of A Securities Upgrade Neutral Buy
2021-02-17 Credit Suisse Maintain Outperform Outperform
2020-11-13 Morgan Stanley Maintain Equal Weight Equal Weight
2020-11-06 Barclays Maintain Overweight Overweight
2020-09-15 UBS Maintain Neutral Neutral
2020-08-20 Morgan Stanley Maintain Equal Weight Equal Weight
2020-08-12 Gabelli & Co. Downgrade Buy Hold
2020-08-10 Barclays Maintain Overweight Overweight
2020-08-10 Truist Securities Maintain Hold Hold
2020-08-10 Citigroup Maintain Neutral Neutral
2020-07-30 Citigroup Maintain Neutral Neutral
2020-07-20 B of A Securities Maintain Neutral Neutral
2020-05-08 Citigroup Maintain Neutral Neutral
2020-05-08 UBS Maintain Neutral Neutral
2020-05-07 Barclays Maintain Overweight Overweight
2020-04-02 Morgan Stanley Maintain Equal Weight Equal Weight
2020-02-19 UBS Maintain Neutral Neutral
2020-02-14 Morgan Stanley Maintain Equal Weight Equal Weight
2020-02-13 CFRA Upgrade Buy Strong Buy
2020-02-12 B of A Securities Maintain Neutral Neutral
2020-02-10 Stifel Maintain Buy Buy
2020-01-09 Stifel Maintain Buy Buy
2019-11-08 JP Morgan Maintain Overweight Overweight
2019-09-30 Morgan Stanley Maintain Equal Weight Equal Weight
2019-08-13 SunTrust Robinson Humphrey Maintain Hold Hold
2019-07-22 Stifel Maintain Buy Buy
2019-07-22 Stifel Nicolaus Maintain Buy Buy
2019-07-01 Bank of America Downgrade Buy Neutral
2019-07-01 B of A Securities Downgrade Buy Neutral
2019-05-09 BMO Capital Maintain Market Perform Market Perform
2019-05-03 Gabelli & Co. Downgrade Buy Hold
2019-04-02 Credit Suisse Maintain Outperform Outperform
2019-03-04 Stifel Upgrade Hold Buy
2019-03-04 Stifel Nicolaus Upgrade Hold Buy
2019-02-25 BMO Capital Maintain Market Perform Market Perform
2018-11-02 JP Morgan Maintain Overweight Overweight
2018-10-15 JP Morgan Upgrade Neutral Overweight
2018-08-22 Stifel Nicolaus Downgrade Buy Hold
2018-08-22 Stifel Downgrade Buy Hold
2018-08-14 Argus Maintain Buy Buy
2018-08-14 Argus Research Maintain Buy Buy
2018-08-03 Morgan Stanley Maintain Equal Weight Equal Weight
2018-08-03 Stifel Maintain Buy Buy
2018-08-03 Stifel Nicolaus Maintain Buy Buy
2018-07-30 B of A Securities Maintain Buy Buy
2018-07-30 Bank of America Maintain Buy Buy
2018-05-05 Argus Maintain Buy Buy
2018-04-05 Credit Suisse Maintain Outperform Outperform
2018-03-19 Morgan Stanley Downgrade Overweight Equal Weight
2018-02-16 Deutsche Bank Maintain Hold Hold
2017-11-29 Morgan Stanley Upgrade Equal Weight Overweight
2017-11-24 UBS Downgrade Buy Neutral
2017-11-03 BMO Capital Maintain Market Perform Market Perform
2017-11-03 Morgan Stanley Maintain Equal Weight Equal Weight
2017-07-26 Deutsche Bank Downgrade Buy Hold
2017-07-17 Deutsche Bank Maintain Buy Buy
2017-06-13 BMO Capital Downgrade Outperform Market Perform
2016-12-15 Cowen & Co. Upgrade Market Perform Outperform
2016-09-09 Argus Maintain Below Average Below Average
2016-09-09 Argus Research Maintain Below Average Below Average
2016-08-04 Jefferies Maintain Buy Buy
2016-08-04 Barclays Maintain Equal Weight Equal Weight
2016-08-04 Citigroup Maintain Neutral Neutral
2016-06-14 Jefferies Maintain Buy Buy
2016-06-10 Citigroup Downgrade Buy Neutral
2016-05-06 Goldman Sachs Downgrade Neutral Sell
2016-03-15 Jefferies Maintain Buy Buy
2015-09-11 BMO Capital Upgrade Market Perform Outperform
2015-08-07 Jefferies Maintain Buy Buy
2015-08-06 William Blair Upgrade Market Perform Outperform
2015-07-23 BMO Capital Maintain Market Perform Market Perform
2015-06-26 BMO Capital Downgrade Outperform Market Perform
2015-06-04 Argus Research Maintain Buy Buy
2015-06-04 Argus Maintain Buy Buy
2015-05-21 Jefferies Maintain Buy Buy
2015-05-06 JP Morgan Maintain Neutral Neutral
2015-05-05 Citigroup Maintain Buy Buy
2015-02-13 JP Morgan Downgrade Overweight Neutral
2015-02-12 Barclays Maintain Equal Weight Equal Weight
2014-11-26 Jefferies Maintain Buy Buy
2014-11-19 JP Morgan Maintain Overweight Overweight
2014-11-19 B of A Securities Maintain Buy Buy
2014-11-19 Bank of America Maintain Buy Buy
2014-11-13 Hilliard Lyons Downgrade Long Term Buy Neutral
2014-11-12 Morgan Stanley Upgrade Underweight Equal Weight
2014-11-12 Bank of America Maintain Buy Buy
2014-11-12 Citigroup Maintain Buy Buy
2014-11-12 Edward Jones Downgrade Buy Hold
2014-11-12 B of A Securities Maintain Buy Buy
2014-11-05 Citigroup Maintain Buy Buy
2014-11-04 Barclays Maintain Equal Weight Equal Weight
2014-10-13 Jefferies Maintain Buy Buy
2014-09-15 Jefferies Maintain Buy Buy
2014-09-10 Hilliard Lyons Maintain Buy Long Term Buy
2014-08-11 Jefferies Maintain Buy Buy
2014-07-14 Jefferies Maintain Buy Buy
2014-05-05 BMO Capital Maintain Outperform Outperform
2014-05-05 Morgan Stanley Downgrade Equal Weight Underweight
2014-04-14 Jefferies Maintain Buy Buy
2014-02-12 William Blair Upgrade Market Perform Outperform
2014-01-08 Morgan Stanley Downgrade Overweight Equal Weight
2013-10-04 Morgan Stanley Upgrade Equal Weight Overweight
2013-07-12 Jefferies Maintain Buy Buy
2013-06-27 BMO Capital Upgrade Market Perform Outperform
2013-06-25 Hilliard Lyons Upgrade Neutral Buy
2013-05-28 Jefferies Maintain Buy Buy
2013-04-02 BMO Capital Maintain Underperform Underperform